Phytoconstituents as emerging therapeutics for breast cancer: Mechanistic insights and clinical implications

Area of Science:

• Oncology
• Pharmacology
• Natural Products Chemistry

Background:

• Breast cancer is a major global health concern, driving the need for innovative therapies.
• Phytoconstituents, bioactive compounds from plants, are gaining attention for their anticancer properties.

Purpose of the Study:

• To review the therapeutic potential of phytoconstituents in breast cancer treatment.
• To explore their mechanisms, including apoptosis induction, proliferation inhibition, metastasis suppression, and anti-angiogenesis.
• To summarize preclinical evidence and discuss synergistic effects with conventional therapies.

Main Methods:

• Comprehensive literature review of in vitro and in vivo studies on phytoconstituents and breast cancer.
• Analysis of mechanisms of action, including cell death pathways and anti-angiogenic effects.
• Evaluation of preclinical data and clinical application challenges.

Main Results:

• Phytoconstituents demonstrate multifaceted anticancer activities, including apoptosis induction and proliferation inhibition.
• These compounds exhibit anti-angiogenic properties, potentially disrupting tumor vascularization.
• Preclinical evidence supports the efficacy of phytoconstituents, with potential for synergistic effects with chemotherapy and radiotherapy.

Conclusions:

• Phytoconstituents represent a promising avenue for breast cancer therapy, offering novel mechanisms and potential for enhanced treatment outcomes.
• Further research is needed to overcome challenges in clinical application and fully integrate these natural compounds into treatment regimens.